A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class ...

President Trump on Friday vowed to impose sweeping tariffs on semiconductor chips, pharmaceuticals, steel and aluminum and oil and gas. “We’ll be doing pharmaceuticals. Importantly in drugs ...

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

semiconductors and pharmaceuticals in a push to increase U.S. production of the products. Trump announced the moves during remarks at a congressional Republican treat at the Trump National Doral ...

and pharmaceutical firms. Governments are encouraged to implement policies that promote the use of these alternatives in processed foods, a segment that contributes significantly to excess sodium ...

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

In today’s fast-paced world, threats can evolve quickly and without warning. As the pharmaceutical industry has operations and supply chains spanning the globe, companies are vulnerable to ...

Ugandan doctors attend the contacts of a patient who had tested positive, during the launch of the vaccination for the Sudan strain of Ebola virus, with a trial vaccine at the Mulago Guest House ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...